Does Wellbutrin (bupropion) help alleviate Attention Deficit Hyperactivity Disorder (ADHD) symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Wellbutrin (bupropion) can be used to help with ADHD symptoms, particularly in patients who have not responded well to stimulants or have co-occurring depression, as it increases levels of dopamine and norepinephrine in the brain, improving attention, focus, and impulse control 1.

Key Points to Consider

  • Typical dosing for ADHD ranges from 150-450 mg daily, often starting at a lower dose and gradually increasing, with the extended-release formulation usually preferred, taken once daily in the morning 1.
  • Improvement may take 1-4 weeks to become noticeable, and common side effects include insomnia, headache, dry mouth, and nausea 1.
  • Wellbutrin carries a lower risk of appetite suppression and growth issues compared to stimulants, making it potentially suitable for certain patients, especially those with concerns about these side effects 1.
  • However, it's crucial to note that stimulant medications like methylphenidate or amphetamine derivatives remain the first-line treatments for ADHD due to their higher efficacy, as supported by a recent meta-analysis proposing methylphenidate for children and adolescents and amphetamines for adults as the preferred therapy 1.

Considerations for Treatment

  • The decision to use Wellbutrin for ADHD should be based on individual patient needs and circumstances, considering the presence of co-occurring conditions such as depression, and the potential benefits and risks of treatment 1.
  • It's also important to weigh the risks of untreated or inadequately treated ADHD, which can lead to significant impairments in functioning and worse mental health outcomes, against the potential benefits of medication 1.

From the Research

Wellbutrin and ADHD Symptoms

  • Wellbutrin, also known as bupropion, is an antidepressant that has been used off-label to treat Attention Deficit Hyperactivity Disorder (ADHD) symptoms 2.
  • A 2017 study found low-quality evidence that bupropion decreased the severity of ADHD symptoms and moderately increased the proportion of participants achieving a significant clinical improvement in ADHD symptoms 2.
  • The study also found that the tolerability of bupropion was similar to that of placebo, suggesting that it may be a viable alternative to stimulants for adults with ADHD 2.

Comparison to Other Treatments

  • Other studies have investigated the use of combination pharmacotherapy for adult ADHD, including the use of stimulants and non-stimulants such as atomoxetine 3, 4.
  • A 2019 study compared the efficacy of methylphenidate and atomoxetine on emotional and behavioral problems in youths with ADHD, finding that both treatments were effective in improving a wide range of emotional/behavioral problems 5.
  • However, the use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder may be problematic and requires careful evaluation 6.

Limitations and Future Research

  • The current evidence for the use of bupropion in ADHD is limited by the small sample sizes and risk of bias in the included studies 2.
  • Further research is needed to fully understand the effects of bupropion on ADHD symptoms and to determine the optimal target population for this treatment 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.

The Cochrane database of systematic reviews, 2017

Research

Combination pharmacotherapy for adult ADHD.

Current psychiatry reports, 2006

Research

Combined methylphenidate and atomoxetine pharmacotherapy in attention deficit hyperactivity disorder.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.